Page last updated: 2024-10-26

fendiline and Brain Neoplasms

fendiline has been researched along with Brain Neoplasms in 1 studies

Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brizzolara, A1
Garbati, P1
Vella, S1
Calderoni, M1
Quattrone, A1
Tonini, GP1
Capasso, M1
Longo, L1
Barbieri, R1
Florio, T1
Pagano, A1

Other Studies

1 other study available for fendiline and Brain Neoplasms

ArticleYear
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment.
    Molecules (Basel, Switzerland), 2020, Nov-10, Volume: 25, Issue:22

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neo

2020